Poolbeg Pharma PLC (POLBF)
USD 0.15
(27.97%)
USD 0.15
(27.97%)
| Breakdown | 2023 | 2022 | 2021 |
|---|---|---|---|
| Revenue | - | - | - |
| Cost of Revenue | 26 Thousand | 26 Thousand | 18 Thousand |
| Gross Profit | -26 Thousand | -26 Thousand | -18 Thousand |
| Operating Expenses | 5.03 Million | 4.98 Million | 2.33 Million |
| Selling, General and Administrative Expenses | 3.37 Million | 3.06 Million | 2.03 Million |
| Research and Development Expenses | 1.67 Million | 2.2 Million | 414 Thousand |
| Other Expenses | -26 Thousand | - | - |
| Cost and Expenses | 5.03 Million | 4.98 Million | 2.33 Million |
| Operating Income | -4.68 Million | -4.98 Million | -2.33 Million |
| Interest Expense | - | - | - |
| Income Tax Expense | 574 Thousand | -91 Thousand | 42 Thousand |
| Earnings before Tax | -4.5 Million | -4.77 Million | -2.33 Million |
| Net Income | -3.93 Million | -4.68 Million | -2.33 Million |
| Earnings Per Share Basic | -0.01 | -9.37 | -0.01 |
| Earnings Per Share Diluted | -0.01 | -9.37 | -0.01 |
| Weighted Average Shares Outstanding | 497.59 Million | 500 Thousand | 317.22 Million |
| Weighted Average Shares Outstanding (Diluted) | 500 Million | 500 Thousand | 317.22 Million |
| Gross Margin | - | - | - |
| EBIT Margin | - | - | - |
| Profit Margin | - | - | - |
| EBITDA | -4.66 Million | -4.96 Million | -3.09 Million |
| Earnings Before Tax Margin | - | - | - |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 13 Thousand | 26 Thousand | - | 13 Thousand | - | 13 Thousand |
| Gross Profit | -13 Thousand | -26 Thousand | - | -13 Thousand | - | -13 Thousand |
| Operating Expenses | 1478.00 | 5.01 Million | 1478.00 | 2.24 Million | 1041.50 | 3.36 Million |
| Selling, General and Administrative Expenses | 990.50 | - | 990.50 | 1.38 Million | 697.50 | 1.81 Million |
| Research and Development Expenses | 406.00 | - | 406.00 | 865 Thousand | 432.50 | 1.54 Million |
| Other Expenses | -13 Thousand | -26 Thousand | - | - | - | - |
| Cost and Expenses | 1478.00 | 5.04 Million | 1478.00 | 2.26 Million | 1041.50 | 3.37 Million |
| Operating Income | -1301.50 | -5.04 Million | -1301.50 | -2.26 Million | -1041.50 | -3.37 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 287.00 | -574 Thousand | 287.00 | - | - | 9000.00 |
| Earnings before Tax | -1347.00 | -4.5 Million | -1347.00 | -1.81 Million | -905.50 | -3.07 Million |
| Net Income | -1060.00 | -3.93 Million | -1060.00 | -1.81 Million | -905.50 | -3.07 Million |
| Earnings Per Share Basic | -0.00 | - | -0.00 | -0.00 | -0.00 | -0.01 |
| Earnings Per Share Diluted | -0.00 | - | -0.00 | -0.00 | -0.00 | -0.01 |
| Weighted Average Shares Outstanding | 493.02 Thousand | 500 Million | 493.02 Thousand | 500 Million | 500 Thousand | 500 Million |
| Weighted Average Shares Outstanding (Diluted) | 500 Thousand | 500 Million | 500 Thousand | 500 Million | 500 Thousand | 500 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -1295.00 | - | -1295.00 | -2.24 Million | -1035.00 | -3.36 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
FSMK
ABMINTLLTD
PTT-R
091810
SCOP
7280